GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wockhardt WOCKPHARMA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,031.50

+4.34%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹33.73bn

FY2017FY2026

Net income

₹2.13bn

FY2017FY2026

Free cash flow

₹640.0m

FY2017FY2026

Shareholders' equity

₹49.40bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹33.73bn₹30.35bn₹28.30bn₹26.57bn₹32.30bn₹27.08bn₹28.44bn₹35.66bn₹39.24bn₹39.66bn
Gross profit₹12.89bn₹18.26bn₹15.98bn₹14.85bn₹18.81bn₹14.98bn₹15.77bn₹18.49bn₹20.70bn₹22.75bn
Research and development₹1.20bn₹1.19bn₹1.32bn₹1.41bn₹1.43bn₹1.72bn₹2.08bn₹2.91bn₹2.87bn₹3.97bn
Operating income₹4.03bn₹10.54bn₹8.36bn₹7.06bn₹9.87bn₹5.33bn₹5.99bn₹6.64bn₹7.54bn₹8.23bn
Net income₹2.13bn−₹470.0m−₹4.63bn−₹5.59bn−₹2.44bn₹6.86bn−₹692.2m−₹1.95bn−₹6.08bn−₹1.96bn
Diluted earnings per share13.11-2.88-30.09-38.73-16.8361.72-6.22-17.57-54.92-17.72

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹86.15bn₹81.35bn₹76.49bn₹76.83bn₹82.43bn₹77.73bn₹81.79bn₹78.31bn₹81.62bn₹89.69bn
Cash and short-term investments₹6.62bn₹6.13bn₹5.23bn₹1.50bn₹3.79bn₹2.38bn₹2.65bn₹4.43bn₹12.97bn₹21.14bn
Total liabilities₹33.34bn₹34.78bn₹39.87bn₹40.21bn₹40.41bn₹40.12bn₹51.21bn₹48.26bn₹49.64bn₹52.50bn
Debt₹22.33bn₹20.21bn₹23.56bn₹21.84bn₹21.98bn₹26.73bn₹35.82bn₹33.75bn₹37.48bn₹41.47bn
Shareholders' equity₹49.40bn₹43.53bn₹33.59bn₹33.54bn₹38.49bn₹33.77bn₹26.72bn₹26.75bn₹28.52bn₹33.37bn
Shares outstanding162m163m154m144m145m111m111m111m111m110m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹2.00bn−₹220.0m₹2.19bn₹1.53bn₹4.13bn−₹2.87bn₹6.49bn₹1.83bn₹684.4m−₹2.69bn
Capital spending−₹1.36bn−₹940.0m−₹2.16bn−₹2.09bn−₹2.12bn−₹1.66bn−₹1.72bn−₹2.75bn−₹3.07bn−₹4.11bn
Free cash flow₹640.0m−₹1.16bn₹30.0m−₹560.0m₹2.01bn−₹4.53bn₹4.77bn−₹915.5m−₹2.39bn−₹6.80bn
Dividends paid————−₹20.0m−₹5.3m−₹5.3m−₹200,000−₹1.0m−₹1.38bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹9.29bn₹9.65bn₹8.88bn₹7.82bn₹7.38bn₹7.66bn₹7.21bn₹8.09bn
Gross profit₹3.51bn₹4.07bn₹5.71bn₹3.10bn₹4.74bn₹4.29bn₹4.59bn₹5.12bn
Operating income₹1.33bn₹1.43bn₹1.68bn₹1.07bn₹3.03bn₹1.42bn₹2.95bn₹3.51bn
Net income₹1.06bn₹1.66bn₹590.0m₹780.0m−₹900.0m−₹250.0m₹140.0m−₹220.0m
Diluted earnings per share6.5210.223.614.77-5.51-1.530.91-1.43
Cash from operations———₹1.89bn—−₹220.0m—₹320.0m
Capital spending———−₹700.0m—−₹3.65bn—−₹2.03bn
Free cash flow———₹1.19bn—−₹3.87bn—−₹1.71bn
Total assets—₹86.15bn—₹85.33bn—₹81.35bn—₹75.88bn
Cash and short-term investments₹6.80bn₹6.62bn₹9.78bn₹9.30bn₹5.88bn₹6.13bn₹2.23bn₹2.58bn
Debt—₹21.95bn—₹24.56bn—₹20.88bn—₹23.43bn
Shareholders' equity₹52.81bn₹49.40bn₹48.76bn₹45.67bn₹46.57bn₹43.53bn₹37.13bn₹33.95bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.3%4.5%-2.7%
Operating income-17.0%-5.4%-10.5%
Net income—-20.9%-1.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin48.6%52.1%53.7%55.0%
Operating margin22.7%25.2%25.3%23.5%
Net margin2.6%-7.2%-2.3%-3.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings147.0-502.5-47.0-10.9-13.36.2-80.0-12.3-8.8-48.4
Price to sales9.37.87.72.31.01.61.90.71.42.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 17 Nov 2016.

FY2017FY2015FY2014FY2008FY2007FY2006FY2005FY2004
Paid in the year9.21518.4313.82310.3674.6084.6084.6082.50
  • 3-for-1 split · 29 Apr 2004

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.